HR19024

· Shanghai Hengrui Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HR19024, covering 2025-03-20 to 2025-03-20. Get the full timeline:

Most recent: Clinical Trial Update: A Study of HR19024 in Subjects With Advanced Solid Tumor [Phase 1]